tiprankstipranks
Trending News
More News >
Towa Pharmaceutical Co (JP:4553)
:4553
Japanese Market

Towa Pharmaceutical Co (4553) Income Statement

Compare
0 Followers

Towa Pharmaceutical Co Income Statement

Last quarter (Q4 2024), Towa Pharmaceutical Co's total revenue was ¥65.86B, an increase of 10.48% from the same quarter last year. In Q4, Towa Pharmaceutical Co's net income was ¥4.36B. See Towa Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 259.59B¥ 227.93B¥ 208.86B¥ 165.62B¥ 154.90B
Gross Profit
¥ 94.73B¥ 81.38B¥ 72.71B¥ 70.19B¥ 65.45B
Operating Expenses
¥ 71.49B¥ 63.74B¥ 67.20B¥ 50.98B¥ 45.53B
Depreciation and Amortization
¥ 20.10B¥ 17.89B¥ 19.41B¥ 10.95B¥ 10.43B
EBITDA
¥ 48.05B¥ 35.54B¥ 24.92B¥ 29.49B¥ 30.35B
Operating Income
¥ 23.24B¥ 17.65B¥ 5.51B¥ 19.20B¥ 19.92B
Other Income/Expenses
¥ 3.09B¥ 6.81B¥ -909.00M¥ 3.04B¥ -1.20B
Pretax Income
¥ 26.33B¥ 24.46B¥ 4.61B¥ 22.25B¥ 18.73B
Net Income
¥ 18.99B¥ 16.17B¥ 2.20B¥ 15.91B¥ 13.96B
Per Share Metrics
Basic EPS
¥ 385.70¥ 328.58¥ 44.72¥ 323.35¥ 283.62
Diluted EPS
¥ 385.70¥ 328.58¥ 43.72¥ 316.19¥ 271.93
Weighted Average Shares Outstanding
49.22M 49.22M 49.22M 49.22M 49.21M
Weighted Average Shares Outstanding (Diluted)
49.22M 49.22M 50.34M 50.32M 51.28M
Currency in JPY

Towa Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis